Gabon has taken a significant step forward in safeguarding its rich biodiversity. From now on, the exploitation and commercialization of iboga, a plant indigenous to Central Africa renowned for its psychotropic and therapeutic qualities, will be subject to stringent governmental authorization. This measure by Libreville effectively secures access to an iconic resource, which for too long was harvested without strict oversight, and whose global economic value has steadily climbed over the past ten years.
A strategic resource under state control
The Tabernanthe iboga, an shrub thriving in Gabon’s equatorial forests, holds a unique position within the nation’s heritage. It is a cornerstone of the Bwiti initiatory rite and is also garnering attention from international biomedical research for its potential applications in treating opiate and cocaine addictions. This dual significance, both cultural and pharmacological, has attracted considerable interest from foreign operators, sometimes leading to the unregulated exploitation of wild populations.
In response to this situation, the Gabonese government now mandates prior administrative authorization for all activities related to iboga, including harvesting, processing, transfer, or export. This framework builds upon protection measures previously adopted, notably since the plant’s classification as national cultural heritage in 2000. Consequently, no commercial operation can proceed without validation from the relevant authorities, with penalties for non-compliance.
Biological sovereignty and combating biopiracy
This decision addresses a long-standing concern among Gabonese authorities and civil society: the appropriation of profits derived from the plant by foreign entities, without adequate benefits for local communities or the state. For years, several clinics in Europe and North America have offered costly treatments based on ibogaine, the alkaloid extracted from the root. Yet, the raw material predominantly originates from Gabon’s forests, where uncontrolled wild harvesting poses a threat to the species’ long-term viability.
By strengthening its legal framework, Libreville empowers itself to track flows, establish quotas, and eventually negotiate access and benefit-sharing agreements in line with the Nagoya Protocol, to which Gabon is a signatory. This approach mirrors that of other Congo Basin states committed to protecting their genetic resources. The challenge remains in scaling up on-the-ground monitoring capabilities across a vast and often inaccessible forest region, where the smuggling of non-timber forest products remains a documented reality.
Structuring a sector between tradition and industry
Beyond its regulatory aspect, this new framework paves the way for the development of a structured national sector. Interested stakeholders, whether traditional practitioners, village cooperatives, or industrial entities, will now navigate a defined administrative process. The nation faces a dual imperative: preserving natural populations, which regenerate slowly, while simultaneously capturing the added value of a plant highly sought after by global pharmaceutical research.
Several operational questions still need to be addressed. What will be the eligibility criteria for authorizations? Which ministry will oversee the application process? What role will be reserved for communities that hold traditional knowledge linked to Bwiti? The credibility of this system will largely hinge on the transparency of procedures and the administration’s ability to balance economic interests with conservation imperatives.
For international investors and partners, the message is clear: iboga is no longer a freely accessible resource. Gabon, which has intensified initiatives to valorize its natural capital in recent years—from carbon credits to forest certification—is now adding another pillar to its ecological sovereignty strategy. The success of this reform will be measured by the human and technical resources the Gabonese transition dedicates to its implementation.
